Skip to main content
SpringerLink
Log in

Dithranol, Vitamin D3-Analoga und 8-Methoxypsoralen

  • Chapter
Dermatologische Externatherapie

Zusammenfassung

Bereits 1877 hat Squire gefunden, dass Goapuder eine Wirkung auf die Psoriasis hat. Als wirksame Substanz stellte sich Chrysarobin heraus. Da es sich bei Goapuder um eine Droge handelte und zudem während des 1. Weltkrieges die Versorgung ins Stocken kam, war es ein Fortschritt, als Galewski (1916) Dithranol synthetisierte, eine Substanz mit ähnlicher Struktur wie Anthrarobin. Dithranol ist somit eine der ältesten Pharmaka, die in der externen Therapie eingesetzt werden.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 19.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 39.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 39.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Ameen M, Chu AC (1999) Treatment of vitiligo with topical calcipotriol. Br J Dermatol 141 Suppl 55: 75

    Google Scholar 

  • Anigbogu ANC, Williams AC, Barry BW (1996) Permeation characteristics of 8 methoxypsoralen through human skin relevance to clinical treatment. J Pharm Pharmacol 48: 356–366

    Article  Google Scholar 

  • Baker BS, Swain AF, Griffiths CEM, Leonard JN, Fry L, Valdimarsson H (1985) The effects of topical treatment with steroids or dithranol on epidermal T lymphocytes and dendritic cells in psoriasis. Scand J Immunol 22: 471–477

    Article  PubMed  CAS  Google Scholar 

  • Barach-Buhles M, Röchling A, El Gammal S, Altmeyer P (1996) The effect of fumaric acid esters and dithranol on acanthosis and hyperproliferation in psoriasis vulgaris. Acta Derm Venereol (Stockh) 76: 190–193

    Google Scholar 

  • Barker JNWN, Ashton R, Marks R, Harris RI, Berth-Jones J (1999) Topical maxacalcitol for the treatment of psoriasis vulgaris: a placebo controlled, double blind, dose finding study with active comparator. Br J Dermatol 141: 274–278

    Article  PubMed  CAS  Google Scholar 

  • Behrens S, Reuther T, Kobyletzki G, Altmeyer P, Kerscher M (1997) Die PUVA Turbantherapie. Hautarzt 48: 842–843

    Article  PubMed  CAS  Google Scholar 

  • Behrens S, Leiter U, Grundmann-Kollmann M, Gruss C, Peter RU, Kerscher M (1998) PUVA Ölbad Therapie mit einem pflanzlich mineralischen Mischpräparat. Akt Dermatol 24: 336–340

    Google Scholar 

  • Berth-Jones J, Chu AC, Dodd WAH, Ganpule M, Griffith WAD, Haydly RP, Kleter MR, Murray SJ, Rogers S, Ivergensen HJ (1992) A multicentre parallel group comparison of calcipotriol ointment and short term dithranol therapy in chronic plaque psoriasis. Br J Dermatol 127: 266–271

    Article  PubMed  CAS  Google Scholar 

  • Berth-Jones J, Bourke J, Iqdal SJ, Hudchinson PE (1993) Urine calcium excretion during treatment of psoriasis with topical calcipotriol. Br J Dermatol 129: 411–414

    Article  PubMed  CAS  Google Scholar 

  • Bourke JF, Berth-Jones J, Iqdal SJ, Hutchinson PE (1993a) High dose topical calcipotriol in the treatment of extensive psoriasis vulgaris. Br J Dermatol 129: 74–76

    Article  PubMed  CAS  Google Scholar 

  • Bourke JF, Berth-Jones J, Hutchinson PE (1993b) Occlusion enhances the efficacy of topical calcipotriol in the treatment of psoriasis vulgaris. Clin Exp Dermatol 18: 504–506

    Article  PubMed  CAS  Google Scholar 

  • Bruse S, Epinette WW, Funicella T, Son A, Jones EL, Los R, McPhee ME, Whitemore C (1994) Comparative study of calcipotriene (MC 903) ointment and fluocinoide ointment in the treatment of psoriasis. J Am Acad Dermatol 31: 755–759

    Article  Google Scholar 

  • Bruynzeel DP, Hol CW, Nieboer C (1992) Allergic contact dermatitis to calcipotriol. Br J Dermatol 127: 66

    Article  PubMed  CAS  Google Scholar 

  • Chang A, Alkemade H, Kerkhof van de PCM (1989) Dithranol modulates the leukotriene B4, induced intraepidermal accumulation of polymorphonuclear leukocytes. J Invest Dermatol 92: 806–808

    Article  PubMed  CAS  Google Scholar 

  • Child EJ, Bellaney GJ, Mc Keon S, Seed P, Basarab T, Setterfield J, Peloux-Monage du H, Eady RAJ (1999) Assessment of a modified dithranol regime for inpatient treatment of psoriasis. Br J Dermatol 141 Suppl 59: 71–72

    Google Scholar 

  • Cripps DJ, Lowe NJ (1979) Photochemotherapy for psoriasis remission times, psoralens and UV-A and combined photochemotherapy with anthralin. Clin Exp Dermatol 4: 477–483

    Article  PubMed  CAS  Google Scholar 

  • Cunliffe WJ, Berth-Jones J, Claudy A, Fairiss G, Goldin D, Gratton D, Hendersson CA, Holden CA, Madin US, Ortonne JP, Youns M (1992) Comparative study of calcipotriol (MC903) ointment and betamethasone 17 -valerate ointment in patients with psoriasis vulgaris. J Am Acad Dermatol 26: 736–743

    Article  PubMed  CAS  Google Scholar 

  • Darley CR, Cunliffe WJ, Green CM, Hutchinson PE, Klaber MR, Downes N (1996) Safety and efficacy of calcipotriol ointment (Dovonex) in treating children with psoriasis vulgaris. Br J Dermatol 135: 390–393

    Article  PubMed  CAS  Google Scholar 

  • Delaney C, Liao W, Cohen M, Fancher M, Kripalani K, Uderman H, Stolz R, Siskin SB (1996) Percutaneous absorption of calcipotriene (calcipotriol) in normal volunteers and psoriatic patients after a single dose of 3H calcipotriene following multiple dose treatment with non radiolabeled calcipotriene 0.005% ointment. J Invest Dermatol Symp Proc 1: 112

    Google Scholar 

  • Dykes PJ, Roberts GP, Marks R (1981) Anthralin cytotoxicity. Br J Dermatol 105 Suppl 20: 43–45

    Article  PubMed  Google Scholar 

  • Elbrecht C, Landes E (1983) Untersuchungen über die Wirksamkeit einer kombinierten Psoriasis Behandlung mit Dithranol und UV-B (SUP). Z Hautkr 58: 387–397

    Google Scholar 

  • Farkas B, Dobozy A, Horváth A, Hunyadi J, Schneider I (1999) Comparison of tacalcitol ointment with short contact dithranol therapy in the treatment of psoriasis vulgaris: a randomized multicentre open prospective study on efficacy and safety. J Dermatol Treatm l0: 93–99

    Article  CAS  Google Scholar 

  • Fiore M (1990) Practical aspects of anthralin therapy. Cutis 46: 351–354

    PubMed  CAS  Google Scholar 

  • Fischer T (1998) Topical PUVA and bath PUVA. In Roenigk HH Jr, Maibach HI (eds). Psoriasis. Marcel Dekkers, New York Basel Hong Kong, pp 565–575

    Google Scholar 

  • Fransje ACM, Castelijns FACM, Gerritsen MJP, Vlijmen-Willems IMJJ van, Erp PH van, Kerkhof CM van de (1999) Proliferation is the main epidermal target in the treatment of psoriatic plaques with once daily application of tacalcitol ointment. Acta Derm Venereol (Stockh) 79: 111–114

    Article  Google Scholar 

  • Frappaz A, Thivolet J (1993) Calcipotriol in combination with PUVA: a randomized double blind placebo study in severe psoriasis. Eur J Dermatol 3: 331–334

    Google Scholar 

  • Fulton JE, Willis I (1968) Photoallergy to methoxsalen. Arch Dermatol 98: 445–450

    Article  PubMed  Google Scholar 

  • Galewsky E (1916) Über Cignolin, ein Ersatzpräparat des Chrysarobin. Dermatol Monatsschr 62: 113–115

    Google Scholar 

  • Gehring W, Ghyczy M, Gloor M, Scheer T, Röding J (1992a) Enhancement of the penetration of dithranol and increase of effect of dithranol on the skin by liposomes. Arzneimittelforschung 42: 982–985

    Google Scholar 

  • Gehring W, Scheer T, Gloor M (1992b) Die Bedeutung der Rezepturgrundlage für die Erythembildung durch Dithranol. Z Hautkr 67: 128–135

    Google Scholar 

  • Gehring W, Klein M, Gloor M (1994) Liposomen als Träger von Dithranol bei der Behandlung der Psoriasis vulgaris. Z Hautkr 69: 451–453

    Google Scholar 

  • Gerittsen MJP, Boezeman JBM, Vlijmen-Willems JMJJ van, Kerkhof PCM van de (1994) The effect of tacalcitol (1,24 (OH)2 D3) on cutaneous inflammation, epidermal proliferation and keratinization in psoriasis: a placebo controlled double blind study. Br J Dermatol 131: 57–63

    Article  Google Scholar 

  • Glade CP, Erp PEJ van, Hooijdonk CAEM van, Elbers ME, Kerkhof UCM van de (1995) Topical treatment of psoriatic plaques with ía,25 - dihydroxyvitamin D3: a multiparameter flow cytometrical analysis of epidermal growth, differentiation and inflammation. Acta Derm Venereol (Stockh) 75: 381–385

    CAS  Google Scholar 

  • Gloor M, Graf R, Wirth H, Landau M (1983) Untersuchungen zur Wirkungsweise einer Psoriasisbehandlung mit Dithranol im Vergleich zu einer Kombinationsbehandlung mit Dithranol und einem Kortikosteroid. Hautarzt 34: 500–503

    PubMed  CAS  Google Scholar 

  • Gómez MI, Azana JM, Arranz I, Harto A, Ledo A (1995) Plasma levels of 8 methoxypsoralen after bath PUVA for psoriasis: relationship to disease severity. Br J Dermatol 133: 37–40

    Article  PubMed  Google Scholar 

  • Gray JD, Bottomley W, Layton AM, Cotteril JA, Monteriro E (1992) The use of calcipotriol in HIV related psoriasis. Clin Exp Dermatol 17: 342–343

    Article  PubMed  CAS  Google Scholar 

  • Grossmann RM, Thivolet J, Claudy A, Souteyrand P, Guilhor JJ, Thomas P, Amblard P, Belaich S de, Belilovsky C, Brassine M de la, Martinet C, Bazex JA, Beylot C, Combermale P, Lambert D, Ostojnic A, Denooeus JP, Lauret PH, Vailant L, Weber M, Pamphile R, Dubertret L (1994) A novel therapeutic approach to psoriasis with combination calcipotriol ointment and very low dose cyclosporine: results of a multicenter placebo controlled study. J Am Acad Dermatol 31: 68–74

    Article  Google Scholar 

  • Groot AC de, Nater JP (1981) Contact allergy to dithranol. Contact Dermatitis 7: 5–8

    Article  PubMed  Google Scholar 

  • Grundmann-Kollmann M, Behrens S, Peter RU, Kerscher M (1999a) Treatment of severe recal-citrant dermatoses of the palms and soles with PUVA bath versus PUVA cream therapy. Photodermatol Photoimmunol Photomed 15: 87–89

    Article  PubMed  CAS  Google Scholar 

  • Grundmann-Kollmann M, Leiter U, Behrens S, Gottlöbe P, Mooser G, Krähn G, Kerscher M (1999b) The time course of phototoxicity of topical PUVA: 8 methoxypsoralen cream PUVA versus 8 methoxypsoralen gel PUVA. Br J Dermatol 190: 988–991

    Article  Google Scholar 

  • Gruss C, Behrens St, Reuther T, Husebo L, Neumann N, Altmeyer P, Lehmann P, Kerscher M (1998) Kinetics of photosensitivity in bath-PUVA photochemotherapy. J Am Acad Dermatol 39: 443–446

    Article  PubMed  CAS  Google Scholar 

  • Hagemann I, Proksch E (1996) Topical treatment by urea reduces epidermal hyperproliferation and induces differentiation in psoriasis. Acta Derm Venereol (Stockh) 76: 353–356

    CAS  Google Scholar 

  • Hagers Handbuch der pharmazeutischen Praxis Bd. 8 (1993). Springer, Berlin Heidelberg New York, S 933–935

    Google Scholar 

  • Hammarström S, Hamberg M, Samuelsson B, Duell E, Stawiski M, Voorhees JJ (1975) Increased concentrations of nonesterified arachidonic acid, 12L-hydroxy-5,8,10,14 - eicostetraenoic acid, prostaglandin Ez,x in epidermis of psoriasis. Proc Natl Acad Sci USA 72: 5130–5134

    Article  PubMed  Google Scholar 

  • Hannuksela M, Karvonen J (1984) Topical trioxsalen PUVA therapy. Acta Derm Venereol Suppl (Stockh) 113: 135–138

    Google Scholar 

  • Hannuksela M, Karvonen J (1989) Carcinogenicity of trioxsalen bath PUVA. J Am Acad Dermatol 21: 813–814

    Article  PubMed  CAS  Google Scholar 

  • Hannuksela A, Pukkala E, Hannuksela M (1996) Cancer incidence among Finnish patients with psoriasis treated with trioxsalen bath PUVA. J Am Acad Dermatol 35: 685–689

    Article  PubMed  CAS  Google Scholar 

  • Hecker D, Martinez J, Sapadin J, Patel B, Lebwohl N (1995) Effects of topical calcipotriene on transmission of ultraviolet light and effect of ultraviolet light on the stability of calcipotriene. J Invest Dermatol 104 Suppl: 659

    Google Scholar 

  • Hulsebosch HJ, Ponec-Waelsch M (1972) The interaction of anthralin, salicylic acid and zinc oxide in pastes. Dermatologica 144: 287–293

    Article  PubMed  CAS  Google Scholar 

  • Huuskonen H, Koulu L, Wilén G (1984) Quantitative determination of methoxsalen in human serum, suction blister fluid and epidermis by gas chromatography mass spectrometry. Photo-dermatology 1: 137–140

    PubMed  CAS  Google Scholar 

  • Jacques Y, Reichert U (1981) Effects of anthralin and analogues on growth and 3H thymidine incorporation in human skin fibroblasts. Br J Dermatol 105 Suppl 20: 45–48

    Article  PubMed  CAS  Google Scholar 

  • Jong EMGJ de, Baadsgaard O (1998) Vitamin D: Rationale and potential mechanism of action. In: Roenigk HH, Maibach HI (eds). Psoriasis. Marcel Dekkers, New York Basel Hong Kong, pp 489–494

    Google Scholar 

  • Kammerau B, Zesch A, Schäfer H (1975) Absolute concentrations of dithranol and triacetyldithranol in the skin layers after local treatment: in vivo investigations with four different types of pharmaceutical vehicles. J Invest Dermatol 64: 145–149

    Article  PubMed  CAS  Google Scholar 

  • Kammerau B, Klebe U, Zesch A, Schäfer H (1976) Penetration, permeation and resorption of 8 methoxypsoralen. Arch Dermatol Res 255: 31–42

    Article  PubMed  CAS  Google Scholar 

  • Kanzler MH, Gorsulowsky DC (1993) Efficacy of topical 5% liquor carbonis detergens vs its emollient base in the treatment of psoriasis. Br J Dermatol 129: 310–314

    Article  PubMed  CAS  Google Scholar 

  • Kemény L, Gross E, Arenberger P, Ruzicka T (1991) Dithranol-induced down-regulation of 12(S)hydroxyeicosatetraenoic acid [12(S)-HETE] receptors in a human epidermal cell line. Arch Dermatol Res 283: 333–336

    Article  PubMed  Google Scholar 

  • Kerkhof PCM van de (1998) An update on vitamin D3 analogues in the treatment of psoriasis. Skin Pharmacol Appl Skin Physiol 11: 2–10

    Article  PubMed  Google Scholar 

  • Kerkhof CPM van de, Hutschinson PE (1996) Topical use of calcipotriol improves outcome in acitretin treated patient with severe psoriasis vulgaris. Br J Dermatol Suppl 135: 30

    Google Scholar 

  • Kerkhof CMP van de, Werfel T, Haustein UF, Luger T, Czarnetzki BM, Niemann R, Plänitz-Stenzel V (1996) Tacalcitol ointment in the treatment of psoriasis vulgaris: a multicentre, placebo controlled, double blind study on efficacy and safety. Br J Dermatol 135: 758–765

    Article  PubMed  Google Scholar 

  • Kerkhof P van de, Vleuten C van der, Gerritsen M, Glade C, Luger Th, Werfel Th, Klüss B (1997) Long term efficacy and safety of once daily treatment of chronic plaque psoriasis with tacalcitol ointment. Eur J Dermatol 7: 421–425

    Google Scholar 

  • Kerscher M, Behrens St (1998) PUVA-Bad-und PUVA Cremetherapie. In: Plewig G, Wolf H (Hrsg). Fortschritte der praktischen Dermatologie und Venerologie. Springer, Berlin Heidelberg New York, S 359–364

    Google Scholar 

  • Kerscher M, Volkenandt M, Plewig G (1993) Combination phototherapy of psoriasis with calcipotriol and narrow band UVB. Lancet 243: 923

    Article  Google Scholar 

  • Kerscher M, Lehmann P, Plewig G (1994) PUVA Bad Therapie Indikationen und praktische Durchführung. Hautarzt 45: 526–528

    Article  PubMed  CAS  Google Scholar 

  • Kirkup ME, Sabroo RA, Kavanagh GM, Downs AMR, Sansom JE, Berker DAR de, Dunnill MGS, Kennedy CTG, Archer CB (1999) Twice daily versus once daily in patient dithranol for psoriasis. Br J Dermatol 141 Suppl 55: 72–73

    Google Scholar 

  • Kokelj F, Plozzer C, Guadagnini A (1996) Topical tacalcitol reduces the total UVB dosage in the treatment of psoriasis vulgaris. J Dermatol Treatm 7: 265–266

    Article  Google Scholar 

  • Koo JYM, Gambia C, Lee J, Siebenlist J (1998) Vitamin D analogues in the treatment of psoriasis. In: Roenigk HH, Maibach HI (eds). Psoriasis, 3. Aufl. Marcel Dekkers, New York Basel Hong Kong, pp 497–506

    Google Scholar 

  • Kraft St, Maibach HI, Shroot B (1998) Dithranol (Anthralin). In: Roenigk HH Jr, Maibach HI (eds). Psoriasis. Marcel Dekkers, New York Basel Hong Kong, pp 435–452

    Google Scholar 

  • Kragballe K (1989) Treatment of psoriasis by the topical application of the novel cholecalciferol analogue calcipotriol (MC 903). Arch Dermatol 125: 1647–1652

    Article  PubMed  CAS  Google Scholar 

  • Kragballe K (1992) Vitamin D analogues in the treatment of psoriasis. J Cell Biochem 49: 46–52

    Article  PubMed  CAS  Google Scholar 

  • Kragballe K, Tore-Gjertzen B, Hoop D (1991) Double blind, right left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis. Lancet 337: 193–196

    Article  PubMed  CAS  Google Scholar 

  • Lambelet P, Löliger J, Shroot B (1988) Role of free radicals in the mode of action of anthralin. Skin Pharmacol 1: 115–121

    Article  PubMed  CAS  Google Scholar 

  • Lawlor F, Hindons C (1982) Allergy to dithranol. Contact Dermatitis 8: 137–138

    Article  PubMed  CAS  Google Scholar 

  • Lawrence GM, Finnen MI, Shuster S (1984) Effect of coal tar on cutaneous aryl hydrocarbon hydroxylase induction and anthralin irritancy. Br J Dermatol 110: 671–675

    Article  PubMed  CAS  Google Scholar 

  • Lebwohl M, Hecker D, Martinez J, Sapadin A, Patel B (1997) Interactions between calcipotriene and ultraviolet light. J Am Acad Dermatol 37: 93–95

    Article  PubMed  CAS  Google Scholar 

  • Lee DY, Cho KH, Minn KW, Son YS (1996) Effects of calcipotriol (MC 903) on proliferation and differentiation of cultured human epidermal keratinocytes. Korean J Dermatol 34: 942–952

    Google Scholar 

  • Lehmann P (1998) Vitamin D-Mono-und Kombinationstherapie. In: Garbe G, Rassner G (Hrsg). Dermatologie Leitlinien und Qualitätssicherung für die Diagnostik und Therapie. Springer, Berlin Heidelberg New York, S 611–612

    Google Scholar 

  • Lindelöf B, Sigurgeirsson B, Tegner E, Larkö O, Berne B (1992) Comparison of the carcinogenic potential of trioxsalen bath PUVA and oral methoxsalen PUVA. A preliminary report. Arch Dermatol 128: 1341–1344

    Article  PubMed  Google Scholar 

  • Lindelöf B, Sigurgeirsson B, Tegner E, Larkö 0, Johannesson A, Berne B, Ljunggren B, Andersson T, Molin L, Nylander-Ljungquist E, Emtestam L (1999) PUVA and cancer risk: the Swedish follow up study. Br J Dermatol 141: 108–112

    Article  PubMed  Google Scholar 

  • Lowe NJ, Breeding J (1981) Anthralin - Different concentration effects on epidermal cell DNA synthesis rates in mice and clinical responses in human psoriasis. Arch Dermatol 117: 698–700

    Article  PubMed  CAS  Google Scholar 

  • Lowe JN, Weingarten D, Bourget R, Moy SL (1986) PUVA therapy for psoriasis: comparison of oral and bath water delivery. J Am Acad Dermatol 14: 754–760

    Article  PubMed  CAS  Google Scholar 

  • Lüftl M, Degitz K, Plewig G (1997) Psoralen bath plus UV A therapy. Possibilities and limitations. Arch Dermatol 133: 1597–1603

    Article  PubMed  Google Scholar 

  • Matsunaga T, Yamamato M, Mimura H (1990) 1,25 (R) Dihydroxyvitamin D 3, a novel active form of vitamin D 3 with high activity for inducing epidermal differentiation but decreased hypercalcaemic activity. J Dermatol 17: 135–142

    PubMed  CAS  Google Scholar 

  • Merk HF, Bickers DR (1992) Dermatopharmakologie und Dermatotherapie. Blackwell Wissenschaft, S 383–412

    Google Scholar 

  • Miller RA (1982) Psoralens and UV-A-induced stellate hyperpigmented freckling. Arch Dermatol 118: 619–620

    Article  PubMed  CAS  Google Scholar 

  • Mohn L and Calcipotriol UVB study group (1999) Topical calcipotriol combined with photo-therapy for psoriasis - the results of two randomized trials and a review of the literature. Dermatology 198: 375–381

    Article  Google Scholar 

  • Mommers JM, Castelijns FACM, Seegers BAMPA, Rossum MM van, Hooijdonk CAEM van, Erp PEJ van, Kerkhof PCM van (1998) The effect of long-term treatment with tacalcitol on the psoriatic epidermis. A flow cytometric analysis. Br J Dermatol 139: 468–471

    Article  PubMed  CAS  Google Scholar 

  • Mommers TM, Meulen AC ter, Erp PEJ van, Kerkhof PCM van de (1999) Influence of tacalcitol on cell cycle kinetics of human keratinocytes following standardized injury. Skin Pharmacol Appl Skin Physiol 12: 174–181

    Article  PubMed  CAS  Google Scholar 

  • Monk BE, Mehir ME, Clement MT, Penmbroke AC, Du Vivier A (1988) Anthralin-corticosteroid combination therapy in the treatment of plaque psoriasis. Arch Dermatol 124: 548–550

    Article  PubMed  CAS  Google Scholar 

  • Müller K, Gawlik I (1996) Inactivation of mouse epidermal 12 - lipoxygenase by anthralin - im-plications for the role of oxygen radicals. Biochem Pharmacol 51: 1173–1179

    Article  PubMed  Google Scholar 

  • Müller K, Kappus (1988) Hydroxyl radical formation by dithranol. J Biochim Pharm 37: 4277–4286

    Article  Google Scholar 

  • Müller K, Prinz H (1997) Antipsoriatic anthrones with modulated redox properties 4. Synthesis and biological activity of novel 9,10-dihydro-9-oxo-2-anthracene-carboxylic and-hydroxamic acids. J Med Chem 4o: 2780–2787

    Article  Google Scholar 

  • Müller K, Seidel M, Braun C, Ziereis K, Wiegrebe W (1991) Dithranol, glucose phosphate dehy-drogenase inhibition and active oxygen species. Arzneimittelforschung 41: 1176–1181

    PubMed  Google Scholar 

  • Müller R, Naumann E, Detmar M, Orfanos CE (1987) Stabilität von Cignolin (Dithranol) in teer-haltigen Salben mit und ohne Salicylsäurezusatz. Hautarzt 38: 107–111

    PubMed  Google Scholar 

  • Nakayama J, Kiryu H, Urabe K, Matsuo S, Shibata S, Koga T, Furue M (1999) Vitamin D3 analogues improve café au lait spots in patients with van Recklingshausen’s disease: experimental and clinical studies. Eur J Dermatol 9: 202–206

    PubMed  CAS  Google Scholar 

  • Neild VS, Scott LV (1982) Plasma levels of 8- methoxypsoralen in psoriatic patients recieving topical 8 methoxypsoralen. Br J Dermatol 106: 199–203

    Article  PubMed  CAS  Google Scholar 

  • Ortonne JP (1994) New therapeutic modality by calcipotriol and betamethason dipropionate. Nouv Dermatol 13: 746–751

    Google Scholar 

  • Parslew R, Friedmann PS (1999) The irritancy of anthralin is inhibited by repeat application of a subirritant concentration. Br J Dermatol 141: 469–474

    Article  PubMed  CAS  Google Scholar 

  • Peters DC, Balfour JA (1997) Tacalcitol. Drugs 54: 265–271

    Article  CAS  Google Scholar 

  • Plewig G, Hofmann C, Braun-Falco O (1978) Photoallergic dermatitis from 8-methoxypsoralen. Arch Dermatol Res 261: 201–211

    Article  PubMed  CAS  Google Scholar 

  • Plumier E, Wappes B, Wiegrebe W (1984) Incorporation of 3H thymidine into DNA: inhibition by dithranol and its di-and triacetate. Arch Dermatol Res 276: 406–408

    Article  PubMed  CAS  Google Scholar 

  • Poskitt BL, Wilkinson JD, Wojnarowska FT (1993) Patchy speckled PUVA pigmentation. J R Soc Med 86: 665–666

    PubMed  CAS  Google Scholar 

  • Prins M, Swinkels QJ, Kolkman EGW, Wuis EW, Hekster YA, Valk PGM van de (1998) Skin irritation by dithranol cream - a blind study to assess the role of the cream formulation. Acta Derm Venereol (Stockh) 78: 262–265

    Article  CAS  Google Scholar 

  • Przybilla B, Kaudewitz P (1987) Ambulante äußerliche Behandlung der Psoriasis vulgaris: Vergleich der Wirksamkeit einer Dithranol-und einer Glukokortikosteroidhaltigen Zubereitung. Z Hautkr 63: 60–62

    Google Scholar 

  • Puschmann M (1983) Experimentelle Untersuchungen zur Erythembildung an der gesunden Haut durch Anthralin. Arztl Kosmetol 13: 207–214

    CAS  Google Scholar 

  • Ramsay CA, Berth-Jones J, Brundin G, Cunliffe WJ, Dubertret L, Kerkhof PCM van de, Wegmann E (1994) Long term use of topical calcipotriol in chronic plaque type psoriasis. Dermatology 189: 260–264

    Article  PubMed  CAS  Google Scholar 

  • Reichert U, Jaques Y, Grangeret M, Schmidt R (1985) Antirespiratory and antiproliferative activity of anthralin in cultured human keratinocytes. J Invest Dermatol 84: 130–134

    Article  PubMed  CAS  Google Scholar 

  • Reuther T, Gruss C, Behrens S, Kobyletzki G, Neumann N, Lehmann P, Kerscher M (1997) Time course of 8 methoxypsoralen induced skin photosensitization in PUVA bath photo chemotherapy. Photodermatol Photoimmunol Photomed 13: 193–196

    Article  PubMed  CAS  Google Scholar 

  • Reuther T, Behrens S, Kobyletzki G, Altmeyer P, Neumann N, Lehmann P, Kerscher M (1998) Kinetik der Photosensibilisierung für die Balneophotochemotherapie mit 8 Methoxypsoralen In: Garbe C, Rassner G (Hrsg). Dermatologische Leitlinien und Qualitätssicherung für die Diagnostik und Therapie. Springer, Berlin Heidelberg New York, S 563–566

    Google Scholar 

  • Rie MAD, Eendenburg JP van, Versnick AC, Stolk IMI, Bos JD, Westerhof W (1995) A new psoralen-containing gel for topical PUVA therapy: development and treatment results in patients with palmoplantar and plaque type psoriasis and hyperkeratotic eczema. Br J Dermatol 132: 964–969

    Article  PubMed  Google Scholar 

  • Röcken M, Messer G, Plewig G (1998) Treatment of psoriasis with vitamin D3 derivates and 311 nm UVB. J Dermatol Treatm 9 Suppl 3: 37–40

    Article  Google Scholar 

  • Roenigk HH Jr (1998) PUVA and skin cancer. In: Roenigk HH jr, Maibach HI (eds). Psoriasis. Marcel Dekkers, New York Basel Hong Kong, pp 577–586

    Google Scholar 

  • Ruzicka Th, Vitto A, Printz MP (1983) Epidermal arachidonate lipoxygenase. Biochim Biophys Acta 751: 359–374

    Google Scholar 

  • Sae Melo Th, Dubertret L, Prognon P, Gond A, Mahuzier G, Santus R (1983) Physicochemical properties and stability of anthralin in model systems and human skin. J Invest Dermatol 80: 1–6

    Article  CAS  Google Scholar 

  • Saihan EM, Albano J, Burton JL (1980) The effect of steroid and dithranol therapy on cyclic nucleotides in psoriatic epidermis. Br J Dermatol 102: 565–569

    Article  PubMed  CAS  Google Scholar 

  • Scarpa C (1996) Tacalcitol ointment is an efficacious and well tolerated treatment for psoriasis. J Eur Art Dermatol Venereol 6: 142–146

    Article  Google Scholar 

  • Scarpa C, Kokelj F, Plozzer C, Lavaroni G, Torsello P (1997) Efficacy and tolerability of tacalcitol administered once daily in the treatment of psoriasis vulgaris (double blind, randomized placebo controlled Italian multicenter study). G Ital Dermatol Venereol 132: 335–338

    Google Scholar 

  • Schäfer H, Zesch A, Stüttgen G (1981) Skin permeability. In: Stüttgen G, Spier HW, Schwarz E (Hrsg). Handbuch der Haut-und Geschlechtskrankheiten, Ergänzungswerk Bd 1/4b. Springer, Berlin Heidelberg, S 541–886

    Google Scholar 

  • Schalla W, Bauer E, Schaefer H (1981) Skin permeability of anthralin. Br J Dermatol 105 Suppl 20: 104–108

    Article  PubMed  CAS  Google Scholar 

  • Schaltegger A, Brunner F, Steiger W, Krebs A (1987) Dithranol: further investigations on the structure-activity relationship - The new series of the 10 - mono-alkyldithranol derivates. Dermatologica 175: 136–141

    Article  PubMed  CAS  Google Scholar 

  • Schauder S, Mahrle G (1982) Kombinierte Einstundentherapie der Psoriasis mit Anthralin und UV-Licht. Hautarzt 33: 206–209

    PubMed  CAS  Google Scholar 

  • Schempp CM, Schöpf E, Simon JC (1996) Phototesting in bath PUVA: marked reduction of 8 methoxypsoralen (8-MOP) activity within one hour after an 8-MOP bath. Photodermatol Photoimmunol Photomed 12: 100–102

    Article  PubMed  CAS  Google Scholar 

  • Schröder JM (1986) Anthralin (1,8-dihydroxyanthrone) is a potent inhibitor of leukotriene pro-duction and LTB4-w oxidation by human neutrophils. J Invest Dermatol 87: 624–629

    Article  PubMed  Google Scholar 

  • Schulze JH (1984) Unterdrückung des Cignolin-bedingten Erythems durch Teer. Z Hautkr 59: 659–662

    PubMed  CAS  Google Scholar 

  • Schulze HJ, Steigleder GK (1984) Erfahrungen bei Halbseitenbehandlung mit Teerzusatz zu Cignolin - Salicylsäure - weißer Vaseline (CVS -)Therapie (TCSV) der Psoriasis vulgaris. Z Hautkr 59: 654–656

    PubMed  CAS  Google Scholar 

  • Seidenari S, Magni R, Gianetti A (1997) Assessment of the activity of tacalcitol on psoriatic plaque by means of colorimetry and high-frequency ultrasound: a double-blind intrasubject half-side right-left comparison with beta-metasone valerate and placebo. Skin Pharmacol l0: 40–47

    Article  CAS  Google Scholar 

  • Shepard SE, Schregenberger N, Dummer R, Pannizon R (1998) Comparison of 8-MOP aqueous bath and 8-MOP ethanolic lotion (melanadinie) in local PUVA therapy. Dermatology 197: 25–30

    Article  Google Scholar 

  • Shroot B, Brown C (1986) Free radicals in skin exposed to dithranol and its derivates. Arzneimittelforschung 36: 1253–1255

    PubMed  CAS  Google Scholar 

  • Squire B (1877) Chrysophanic acid as a remedy in skin disease. Med J 1: 199–200

    Article  CAS  Google Scholar 

  • Staberg B, Roed-Petersen J, Menné J (1989) Efficacy of topical treatment in psoriasis with MC 903 a new vitamin D analogue. Acta Derm Venereol (Stockh) 69: 147–150

    CAS  Google Scholar 

  • Stege H, Berneburg M, Ruzicka Th, Krutmann J (1997) Creme PUVA Photochemotherapie. Hautarzt 48: 89–93

    Article  PubMed  CAS  Google Scholar 

  • Streit V, Wedow O, Christophers E (1994) Innovative Balneophototherapie mit reduziertem Badevolumina. Hautarzt 45: 140–144

    Article  PubMed  CAS  Google Scholar 

  • Swanbeck G, Lundquist P (1972) Ultrastructural changes of mitochondria in dithranol-treated psoriatic epidermis. Acta Derm Venereol (Stockh) 52: 94–98

    Google Scholar 

  • Takashima A, Yamamoto K, Kimura S, Takakuwa Y, Micuno N (1991) Allergic contact and photocontact dermatitis due to psoralens in patients with psoriasis treated with topical PUVA. Br J Dermatol 124: 37–42

    Article  PubMed  CAS  Google Scholar 

  • Taube KH, Fiedler H, Wohlrab W, Wozniak KD (1985) Untersuchungen zur Kurzzeittherapie der Psoriasis vulgaris mit Dithranol unter Harnstoffzusatz. Dermatol Monatsschr 171: 650–653

    PubMed  CAS  Google Scholar 

  • Thaci D, Berna A, Holzmann H, Kaufmann R (1998) Tacalcitol in combination with UVB-in vitro effects. J Dermatol Treatm 9, Suppl 3: 31–36

    Article  Google Scholar 

  • Tham SM, Lun KC, Cheong WK (1994) A comparative study of calipotriol ointment and tar in chronic plaque psoriasis. Br J Dermatol 131: 673–677

    Article  PubMed  CAS  Google Scholar 

  • Thoma K, Holzmann Ch (1997) Dithranol Präparate. Dtsch Apoth Z 137: 54–67

    Google Scholar 

  • Trasciatti S, Canali S, Palmubo R, Zeppa S (1993) Pharmacokinetics of 3H tacalcitol in psoriatic patients In: Book of Abstracts 3th Congress of the European Academy of Dermatology and Venereology Copenhagen, p 21

    Google Scholar 

  • Unna EG (1916) Cignolin als Heilmittel der Psoriasis. Dermatol Monatsschr 62: 116–137

    Google Scholar 

  • Vallat PV, Gilleaudeau P, Battat L, Wolfe J, Nabeya R, Heftier N, Hodak E, Gottlieb AB, Krueger JG (1994) PUVA bath therapy strongly suppresses immunological and epidermal acitivation in psoriasis: a possible cellular basis for remittive therapy. J Exp Med 180: 283–296

    Article  PubMed  CAS  Google Scholar 

  • Veien NK, Bjerke JR, Rossmann-Ringdahl I, Jakobsen HB (1997) Once daily treatment of psoriasis with tacalcitol compared with twice daily treatment with calcipotriol-A double blind trial. Br J Dermatol 137: 581–586

    Article  PubMed  CAS  Google Scholar 

  • Vleuthen CHM van der, Gerritsen MJP, Jong EMGJ de, Elbers M, Jongh GJ de, Kerkhof PCM van de (1986) A novel dithranol formulation (Micanol): the effects of monotherapy and UVB combination therapy on epidermal differentiation, proliferation and cutaneous inflammation in psoriasis vulgaris. Acta Derm Venereol (Stockh) 76: 387–391

    Google Scholar 

  • Wang JCT, Pätel BG, Ehmann CW, Lowe N (1987) The release and percutaneous permeation of anthralin products, using clinically involved and uninvolved psoriatic skin. J Am Acad Dermatol 16: 812–821

    Article  PubMed  CAS  Google Scholar 

  • Wiegrebe W, Retzow A, Plumier E, Ersoy N, Garbe A, Faro HP, Kunert R (1984) Dermal absorption and metabolism of the antipsoriatic drug dithranol triacetate. Arzneimittelforschung 34: 48–51

    PubMed  CAS  Google Scholar 

  • Willis I, Harris DR (1973) Resistant psoriasis. Combined methoxalen-anthralin therapy. Arch Dermatol 107: 358–362

    Article  PubMed  CAS  Google Scholar 

  • Wohlrab W (1977) Die therapeutische Harnstoffwirkung auf die Haut. Dermatologica 155: 97109

    Article  Google Scholar 

  • Yip J, Goodfield M (1991) Contact dermatitis from MC 903, a topical vitamin D3 analogue. Contact Dermatitis 25: 139–140

    Article  PubMed  CAS  Google Scholar 

  • Youn JI, Park BS, Chung JH, Lee JH (1997) Photoprotective effect of calcipotriol upon skin photo-reaction UVA and UVB. Photodermatol Photoimmunol Photomed 13: 109–113

    Article  PubMed  CAS  Google Scholar 

  • Zwart AJ de, Jong EMGJ de, Kerkhof PCM van de (1992) Topical application of dithranol on normal skin induces epidermal hyperproliferation and increased Ks8.12 binding Skin Pharmacol 5: 34–40

    Google Scholar 

Download references

Authors
  1. M. Gloor
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Gloor, M. (2000). Dithranol, Vitamin D3-Analoga und 8-Methoxypsoralen. In: Dermatologische Externatherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-58308-7_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-58308-7_14

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-63533-5

  • Online ISBN: 978-3-642-58308-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation